The first 30 years of the American Academy of Dermatology skin cancer screening program: 1985-2014

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

卷:79

Article

Okhovat, Jean-Phillip^1,2,5  Beaulieu, Derek⁸  Tsao, Hensin³  Halpern, Allan C.⁹  Michaud, Dominique S.⁷  Shaykevich, Shimon⁴  Geller, Alan C.⁶ 

[1] Stanford Hosp & Clin, Stanford Canc Ctr, Dept Dermatol, Boston, MA USA

[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA

[3] Massachusetts Gen Hosp, Dept Dermatol, Wellman Ctr Photomed, Boston, MA 02114 USA

[4] Harvard Med Sch, Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA USA

[5] Harvard TH Chan Sch Publ Hlth, Dept Biostat & Epidemiol, Boston, MA 02115 USA

[6] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA

[7] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA

[8] Tufts Clin & Translat Sci Inst, Boston, MA USA

[9] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY 10021 USA

关键词: access to care;    clinical diagnoses;    melanoma;    risk factors;    screening;    skin cancer;   

DOI  :  10.1016/j.jaad.2018.05.1242

来源: Elsevier

【 摘 要 】

Background: The incidence of melanoma is rising faster than that of any other preventable cancer in the United States. The American Academy of Dermatology has sponsored free skin cancer education and screenings conducted by volunteer dermatologists in the United States since 1985. Objective: We aimed to assess the American Academy of Dermatology's national skin cancer screening program from 1986 to 2014 by analyzing the risk factor profile, access to dermatologic services, and examination results. Methods: We conducted several detailed statistical analyses of the screening population. Results: From 1986 to 2014, records were available for 2,046,531 screenings, 1,963,141 (96%) of which were subjected to detailed analysis. Men comprised 38% of all participants. The number of annual screenings reached approximately 100,000 in 1990 and remained relatively stable thereafter. From 1991 to 2014 (data for 1995, 1996 and 2000 were unavailable), clinical diagnoses were rendered for 20,628 melanomas, 156,087 dysplastic nevi, 32,893 squamous cell carcinomas, and 129,848 basal cell carcinomas. Only 21% of screenees had a regular dermatologist. Those with a clinical diagnosis of skin cancer were more likely than the general screening population to be uninsured. Limitations: Inability to verify clinical diagnoses histopathologically. Conclusion: Our findings suggest that the SPOTme program has detected thousands of skin cancers that may have gone undetected or experienced a delay in detection.

【 授权许可】

Free